CK0801 for Treatment of Aplastic Anemia

Clinical trial NCT07499102 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07499102
Sponsor: Cellenkos, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Aplastic Anemia

Start date: 2026-08-03
Primary completion: 2028-08-03
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.